A detailed history of Global Retirement Partners, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 307 shares of BIIB stock, worth $48,509. This represents 0.0% of its overall portfolio holdings.

Number of Shares
307
Previous 380 19.21%
Holding current value
$48,509
Previous $88,000 32.95%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$189.07 - $236.8 $13,802 - $17,286
-73 Reduced 19.21%
307 $59,000
Q2 2024

Jul 23, 2024

BUY
$190.52 - $236.72 $39,437 - $49,001
207 Added 119.65%
380 $88,000
Q1 2024

Apr 23, 2024

SELL
$212.02 - $267.71 $19,081 - $24,093
-90 Reduced 34.22%
173 $37,000
Q4 2023

Jan 18, 2024

BUY
$222.59 - $267.94 $23,817 - $28,669
107 Added 68.59%
263 $68,000
Q3 2023

Oct 13, 2023

BUY
$253.3 - $285.89 $6,839 - $7,719
27 Added 20.93%
156 $40,000
Q2 2023

Jul 20, 2023

BUY
$275.25 - $318.06 $275 - $318
1 Added 0.78%
129 $36,000
Q1 2023

May 05, 2023

BUY
$256.56 - $292.34 $14,880 - $16,955
58 Added 82.86%
128 $35,000
Q4 2022

Feb 13, 2023

SELL
$252.44 - $306.72 $504 - $613
-2 Reduced 2.78%
70 $19,000
Q3 2022

Nov 03, 2022

BUY
$194.69 - $268.46 $778 - $1,073
4 Added 5.88%
72 $20,000
Q2 2022

Jul 15, 2022

BUY
$187.54 - $223.02 $750 - $892
4 Added 6.25%
68 $14,000
Q1 2022

Jul 14, 2022

BUY
$193.77 - $244.14 $12,401 - $15,624
64 New
64 $13,000
Q4 2021

Jan 21, 2022

SELL
$223.92 - $287.77 $13,435 - $17,266
-60 Closed
0 $0
Q3 2021

Oct 22, 2021

BUY
$282.99 - $369.05 $3,961 - $5,166
14 Added 30.43%
60 $17,000
Q2 2021

Jul 15, 2021

BUY
$259.0 - $414.71 $7,252 - $11,611
28 Added 155.56%
46 $16,000
Q2 2020

Jul 13, 2020

SELL
$258.66 - $342.55 $1,551 - $2,055
-6 Reduced 25.0%
18 $5,000
Q1 2020

Apr 28, 2020

SELL
$268.85 - $341.04 $12,098 - $15,346
-45 Reduced 65.22%
24 $8,000
Q4 2019

Jan 23, 2020

SELL
$220.06 - $304.07 $2,200 - $3,040
-10 Reduced 12.66%
69 $20,000
Q3 2019

Nov 19, 2019

SELL
$217.44 - $243.88 $17,830 - $19,998
-82 Reduced 50.93%
79 $18,000
Q2 2019

Nov 19, 2019

SELL
$219.29 - $241.72 $8,333 - $9,185
-38 Reduced 19.1%
161 $38,000
Q1 2019

May 07, 2019

SELL
$216.71 - $338.96 $2,167 - $3,389
-10 Reduced 4.78%
199 $47,000
Q4 2018

Feb 22, 2019

SELL
$278.5 - $352.75 $1,671 - $2,116
-6 Reduced 2.79%
209 $63,000
Q3 2018

Oct 17, 2018

BUY
$293.51 - $383.83 $2,054 - $2,686
7 Added 3.37%
215 $76,000
Q2 2018

Aug 13, 2018

BUY
$257.52 - $306.91 $14,163 - $16,880
55 Added 35.95%
208 $60,000
Q1 2018

Aug 10, 2018

BUY
$260.13 - $367.91 $23,151 - $32,743
89 Added 139.06%
153 $42,000
Q4 2017

Aug 13, 2018

SELL
$307.64 - $344.58 $5,229 - $5,857
-17 Reduced 20.99%
64 $20,000
Q3 2017

Aug 10, 2018

BUY
$281.15 - $329.69 $1,124 - $1,318
4 Added 5.19%
81 $25,000
Q1 2017

Aug 10, 2018

BUY
N/A
6 Added 8.45%
77 $21,000
Q4 2016

Aug 10, 2018

BUY
N/A
71
71 $20,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.8B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.